Table 3 Primary care and diagnostic intervals (in days) for lung cancer patients with a referral route involving the GP, according to groups. Only GP-involved patients are included in the analyses. Adjusted and unadjusted associations for long intervals (the 75 percentile from 2010) are presented as prevalence ratios (PRs) with 95 % confidence intervals (95 % CI)

N

Median

IQI

p-value

Prevalence of long interval

PR (95 % CI) Unadjusted

PR (95 % CI) adjusted^a

N

Median

IQI

p-value

Prevalence of long interval

PR (95 % CI) Unadjusted

PR (95 % CI) adjusted^a

All

155

16

4–56

36.1 (28.6–44.2)

160

39

17–93

33.1 (25.9–41.0)

Controls

74

18

5–69

36.5 (25.6–48.5)

1

1

75

44

17–112

37.3 (26.4–49.3)

1

1

Intervention

81

14

4–53

0.455^d

35.8 (25.4–47.2)

0.98 (0.65–1.49)

0.99 (0.65–1.54)

85

36

17–83

0.299^d

29.4 (20.0–40.3)

0.79 (0.51–1.23)

0.80 (0.50–1.27)

Intervention:

- CME^b

32

37

8–61

53.1 (34.7–70.9)

1

1

35

66

22–143

42.9 (26.3–60.6)

1

1

+ CME^c

49

9

3–27

0.048^d

24.5 (13.3–38.9)

0.46 (0.26–0.83)

0.49 (0.27–0.88)

50

23

15–50

0.008^d

20.0 (10.0–33.7)

0.47 (0.24–0.92)

0.45 (0.20–1.03)